Our Blog

Posts Categorized: Chemotherapy

Breast cancer survivor recommends seeking a second opinion

Published On: | Eric Brown

It’s been 12 years since Registered Nurse Cory Pacheco heard the one word every single person fears … cancer. “When I got that phone call, it sucked the life right out of me,” she recalls vividly. “I eat right, I exercise regularly, I don’t smoke, I drink socially … I do everything I can to […]

Learn More

The Role of a Breast Care Navigator

Published On: | Eric Brown

When a woman finds out she has breast cancer, in many cases she needs someone to “hold her hand” through this unanticipated and frightening journey into the unknown. Women face a confusing maze of questions and often become overwhelmed very quickly. As physicians, we do our best to provide as much support and information as […]

Learn More

Chemotherapy and fear are not hand in hand

Published On: | Eric Brown

You just learned you have cancer. Your life is about to turn upside down. Your mind is racing 100 miles an hour with all kinds of fears and worries when you hear another frightening word – chemotherapy. Now, panic and anxiety overwhelm you. Question after question pops into your head … what will happen to […]

Learn More

Can hair loss from chemotherapy be prevented?

Published On: | Kylie Chin

Hair loss (alopecia) is an unfortunate side effect of chemotherapy, but breast cancer researchers are experimenting with scalp hypothermia (cryotherapy or cold-cap therapy)—a technique that uses a special head-cap to protect against chemo-induced alopecia. According to the NY Daily News, a scalp-cooling device known as a DigniCap may soon be available in the U.S., and […]

Learn More

New Pre-Surgical (Neoadjuvant) Breast Cancer Drug is on the Road to Approval

Published On: | Kylie Chin

Roche, a Swiss global health-care company, has recently received a positive review from the Food and Drug Administration (FDA) concerning their new pre-surgical breast cancer treatment drug, Perjeta. In actuality, a positive review is an understatement. FDA scientists are recommending accelerating the approval process for the drug, a measure usually reserved for pioneering drugs that […]

Learn More